SFX by Ex Libris Inc.

Title:	Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
Source:	Nucleic Acids Research [0305-1048] Chan, S C yr:2015

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Boysen, G. "SPOP mutation leads to genomic instability in prostate cancer." eLife 4.September (2015).
description	2.	Taki, S. "Multistage regulation of Th1-type immune responses by the transcription factor IRF-1." Immunity 6.6 (1997): 673-679.
description	3.	Zhu, Lihua J. "ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data." BMC bioinformatics 11.1 (2010): 237-237.
description	4.	Azad, A. "Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer." Clinical cancer research 21.10 (2015): 2315-24.
description	5.	Boeva, V. "De novo motif identification improves the accuracy of predicting transcription factor binding sites in ChIP-Seq data analysis." Nucleic Acids Research 38.11 (2010).
description	6.	Wirleitner, B. "Down-regulatory effect of N-chlorotaurine on tryptophan degradation and neopterin production in human PBMC." Immunology letters 93.2 (2004): 143-149.
description	7.	Chen, L. "hmChIP: a database and web server for exploring publicly available human and mouse ChIP-seq and ChIP-chip data." Bioinformatics 27.10 (2011): 1447-1448.
description	8.	Wang, D. "Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA." Nature 474.7351 (2011): 390-394.
description	9.	Lohoff, M. "Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo." Immunity 6.6 (1997): 681-9.
description	10.	Kluger, C. "Dendritic cells require a systemic type I interferon response to mature and induce CD4(+) Th1 immunity with poly IC as adjuvant." The Journal of experimental medicine 206.7 (2009): 1589-1602.
description	11.	Kamijo, R. "Requirement for transcription factor IRF-1 in NO synthase induction in macrophages." Science 263.5153 (1994): 1612-5.
description	12.	Kong, D. "Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes." The Prostate 75.2 (2014): 161-74.
description	13.	Phillips, R. "Prostate cancer: Probing progression in circulating tumour cells." Nature reviews. Urology 11.9 (2014): 486-.
description	14.	Wee, Zhen N. "EZH2-Mediated Inactivation of IFN-Î³-JAK-STAT1 Signaling Is an Effective Therapeutic Target in MYC-Driven Prostate Cancer." Cell Reports 8.1 (2014): 204-216.
description	15.	Brenner, Arul Y. "Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer." Cancer cell 19.5 (2011): 664-78.
description	16.	Zhao, David Y. "Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor." Nature medicine 6.6 (2000): 703-6.
description	17.	BÃrubÃ, Nathalie G. "Dual Effect of CTCF Loss on Neuroprogenitor Differentiation and Survival." The Journal of neuroscience 34.8 (2014): 2860-2870.
description	18.	Dand, N. "BioGranat-IG: a network analysis tool to suggest mechanisms of genetic heterogeneity from exome-sequencing data." Bioinformatics 29.6 (2013): 733-741.
description	19.	Martinez, Selena R. "CTCF terminal segments are unstructured." Protein science (2010): 1110-1116.
description	20.	Fuertes Marraco, H. "Type I Interferon Drives Dendritic Cell Apoptosis via Multiple BH3-Only Proteins following Activation by PolyIC In Vivo." PLoS ONE 6.6 (2011).